|
ZNF222 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.3578999998668E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96249999995235E-06 |
| Normal-vs-Stage2 |
9.717800E-03 |
| Normal-vs-Stage3 |
3.77550000000282E-05 |
| Normal-vs-Stage4 |
2.65959999579124E-08 |
| Stage1-vs-Stage2 |
9.087000E-01 |
| Stage1-vs-Stage3 |
1.315180E-01 |
| Stage1-vs-Stage4 |
8.235300E-03 |
| Stage2-vs-Stage3 |
2.802400E-01 |
| Stage2-vs-Stage4 |
2.431800E-02 |
| Stage3-vs-Stage4 |
1.528440E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.79789999952018E-07 |
| Normal-vs-AfricanAmerican |
2.442300E-03 |
| Normal-vs-Asian |
8.475600E-02 |
| Caucasian-vs-AfricanAmerican |
1.930360E-01 |
| Caucasian-vs-Asian |
6.727400E-01 |
| AfricanAmerican-vs-Asian |
9.675000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.17530000071287E-08 |
| Normal-vs-Female |
3.891900E-02 |
| Male-vs-Female |
1.358680E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.818500E-03 |
| Normal-vs-Extreme_Weight |
7.07369995911478E-09 |
| Normal-vs-Obese |
3.374500E-04 |
| Normal-vs-Extreme_Obese |
5.497700E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.354300E-02 |
| Normal_Weight-vs-Obese |
6.056200E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.074800E-01 |
| Extreme_Weight-vs-Obese |
7.013500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.528000E-01 |
| Obese-vs-Extreme_Obese |
5.606400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.675700E-02 |
| Normal-vs-Age(41-60Yrs) |
2.3818999999925E-05 |
| Normal-vs-Age(61-80Yrs) |
1.06649999997988E-06 |
| Normal-vs-Age(81-100Yrs) |
2.02559999999963E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.702200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.383000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.211590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.062800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.223820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.807600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.98308000000091E-05 |
| Normal-VS-Type2 PRCC |
1.01429999954661E-08 |
| Normal-VS-KIRP CIMP |
7.171900E-02 |
| Normal-VS-Unclassified PRCC |
1.441250E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.727520E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.839600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.886200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.213400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.717700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.535400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.28139999949961E-07 |
| Normal-vs-N1 |
2.760700E-03 |
| Normal-vs-N2 |
1.222190E-03 |
| N0-vs-N1 |
6.247400E-01 |
| N0-vs-N2 |
5.253800E-01 |
| N1-vs-N2 |
1.626390E-01 |
|
|
